Characterization of the LxxLL motif in the aryl hydrocarbon receptor: Effects on subcellular localization and transcriptional activity

被引:22
|
作者
Ikuta, T [1 ]
Watanabe, J [1 ]
Kawajiri, K [1 ]
机构
[1] Saitama Canc Ctr, Res Inst, Ina, Saitama 3620806, Japan
来源
JOURNAL OF BIOCHEMISTRY | 2002年 / 131卷 / 01期
关键词
aryl hydrocarbon (TCDD) receptor; CYP1A1; HSP90; LxxLL motif;
D O I
10.1093/oxfordjournals.jbchem.a003080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that acts in concert with the AhR nuclear translocator (ARNT). Subcellular localization and transcriptional activation of target genes are mainly regulated by ligands such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). We have previously reported that AhR migrates in cells as a nucleocytoplasmic shuttling protein mediated by its nuclear localization and export signals. A short sequence motif LxxLL (L is leucine and x is any amino acid) found in transcriptional co-activators has been reported to mediate the binding to liganded nuclear receptors. The role of the two LxxLL motifs, AhR[50-54] and [224-228], has now been analyzed by determining the localization of AhR and its transcriptional activity with Leu to Ala mutations in full-length AhR. Immunocytostaining revealed that mutation of the motif at AhR[50-54] promotes the efficiency of nuclear localization in the absence of ligand without altering HSP90 and ARA9 binding or nuclear export activity. Furthermore, this mutation decreases the transcriptional activity of the AhR/ARNT system, which is likely due to the suppression of AhR/ARNT/XRE complex formation. Another LxxLL motif at AhR[224-227] affects neither the subcellular localization nor transcriptional activity. These results indicate that the LxxLL motif at AhR[50-54] is important for the regulation of AhR activity.
引用
收藏
页码:79 / 85
页数:7
相关论文
共 50 条
  • [1] Regulation of subcellular localization of the aryl hydrocarbon receptor (Ahr)
    Richter, CA
    Tillitt, DE
    Hannink, M
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 389 (02) : 207 - 217
  • [2] Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation
    McInerney, EM
    Rose, DW
    Flynn, SE
    Westin, S
    Mullen, TM
    Krones, A
    Inostroza, J
    Torchia, J
    Nolte, RT
    Assa-Munt, N
    Milburn, MV
    Glass, CK
    Rosenfeld, MG
    GENES & DEVELOPMENT, 1998, 12 (21) : 3357 - 3368
  • [3] SUBCELLULAR-LOCALIZATION OF CUTANEOUS ARYL-HYDROCARBON HYDROXYLASE-ACTIVITY
    BICKERS, DR
    CLINICAL RESEARCH, 1975, 23 (03): : A450 - A450
  • [4] SUBCELLULAR-LOCALIZATION OF CUTANEOUS ARYL-HYDROCARBON HYDROXYLASE-ACTIVITY
    BICKERS, DR
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1975, 51 (10) : 1148 - 1148
  • [5] SUBCELLULAR-LOCALIZATION OF CUTANEOUS ARYL-HYDROCARBON HYDROXYLASE-ACTIVITY
    BICKERS, DR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1975, 64 (03) : 205 - 205
  • [6] Expression, Localization, and Activity of the Aryl Hydrocarbon Receptor in the Human Placenta
    Wakx, Anais
    Nedder, Margaux
    Tomkiewicz-Raulet, Celine
    Dalmasso, Jessica
    Chissey, Audrey
    Boland, Sonja
    Vibert, Francoise
    Degrelle, Severine A.
    Fournier, Thierry
    Coumoul, Xavier
    Gil, Sophie
    Ferecatu, Ioana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
  • [7] SUBCELLULAR LOCALIZATION OF HUMAN PLACENTAL ARYL HYDROCARBON HYDROXYLASE
    JUCHAU, MR
    SMUCKLER, EA
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1973, 26 (02) : 163 - 179
  • [8] Novel cell line for assessment of aryl hydrocarbon receptor transcriptional activity
    Novotna, Aneta
    Dvorak, Zdenek
    Pavek, Petr
    TOXICOLOGY LETTERS, 2012, 211 : S77 - S77
  • [9] Repression of Aryl Hydrocarbon Receptor Transcriptional Activity by Epidermal Growth Factor
    Hankinson, Oliver
    MOLECULAR INTERVENTIONS, 2009, 9 (03) : 116 - 118
  • [10] Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activity
    Li, Henan
    Fidler, Matthew L.
    Lim, Carol S.
    MOLECULAR PHARMACEUTICS, 2005, 2 (06) : 509 - 518